This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Third View: Discussing GSK's recent positive data from Phase II seasonal influenza mRNA vaccine programme.

Ticker(s): GSK

Who's the expert?

Institution: Family Care of Fox Cities

  • Board Certified Family Medicine Physician
  • Recommends meningitis to roughly 20 patients weekly
  • Familiar with the phase 3 MenABCWY Noninferiority study

Interview Goal
This conversation will focus on GSK's recent Phase II data for their seasonal influenza mRNA vaccine.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.